Total planned funding: $104,007,220
Allocations
Countries/Regions
Ukraine | $104,007,220 |
Organizational Types
Private Contractor | $28,578,578 |
NGO | $20,937,998 |
Unknown | $19,500,220 |
Own Agency | $11,890,744 |
Multi-lateral Agency | $10,288,586 |
Other USG Agency | $4,589,094 |
University | $4,150,000 |
Implementing Agency | $4,072,000 |
Program Areas
Governance and Systems | $44,299,368 |
Treatment | $22,102,678 |
Prevention | $12,373,845 |
Testing | $9,274,026 |
Management and Operations | $8,310,322 |
Care | $7,234,281 |
Budget Codes
OHSS: Health Systems Strengthening | $22,462,503 |
HVSI: Strategic Information | $12,091,601 |
HTXD: Treatment: ARV Drugs | $11,405,290 |
HTXS: Treatment: Adult Treatment | $10,697,388 |
HLAB: Laboratory Infrastructure | $9,745,264 |
HVCT: Testing: HIV Testing and Counseling | $9,274,026 |
HVMS: Management and Operations | $8,310,322 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $5,947,216 |
HVTB: Care: TB/HIV | $4,600,861 |
HVOP: Sexual Prevention: Other Sexual Prevention | $4,211,597 |
HMBL: Biomedical Prevention: Blood Safety | $2,142,932 |
HBHC: Care: Adult Care and Support | $1,586,341 |
HKID: Care: Orphans and Vulnerable Children | $1,047,079 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $72,100 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $0 |
Top Partner Programs
Not Available:
$20,204,936
Countries/Regions
Chemonics International:
$16,839,470
Countries/Regions
USG Aggregated Agencies:
$10,541,744
Countries/Regions
Deloitte Consulting Limited:
$10,239,108
Countries/Regions